United States · 
Who invested in Neurogene?
Neurogene's investors include Cormorant Asset Management, Redmile Group, Samsara BioCapital, BlackRock and Janus Henderson Investors, and 1 more on record.
20192020202120222023202420252026
$69MSeries A$125MRound
United States · Funded startup
Who invested in Neurogene
Funding summaryUpdated 26 Oct 2026
$194Mraised across 2 rounds since 2019, from 2 sources
$69MSeries A$125MRound
- Latest round
- Round, $125MJul 2026
- Step-upi
- 1.8×
- Investors
- 6
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $69M Feb 2019
- Biggest round
- $125M Round · Jul 2026
- Between rounds
- 7.4 years from the last two
The rounds
- Jul 2026Round$125M2 new3 returning
Source recorded
- Feb 2019Series A$69M4 new
Reported by FinSMEsSEC filing: $38M sold, first sale Feb 2019
Founders and team
From Neurogene's own website and the SEC filings it signed: 7 on the team.
- Rohan PalekarChief Executive Officer
- Arvind SreedharanSenior Vice President, Business Operations
- Ricardo JimenezSenior Vice President, Technical Operations
- Christy ShaferChief Commercial Officer
- Keith WoodsChief Operating Officer
- Christine Mikail CvijicExecutive Officeri
- Rachel McMinnExecutive Officer, Directori
On the board, as filediCaroline Mikail StoutCory Mikail FreedlandRobert Mikail BaffiSrdjan Mikail StankovicStephen Mikail Biggar
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2019Round2026
Cormorant Asset Management
Redmile Group
Samsara BioCapital
BlackRock
Janus Henderson InvestorsEcorR1
Cormorant Asset ManagementRedmile GroupSamsara BioCapitalBlackRockJanus Henderson InvestorsEcorR1Everyone who backed them
EcorR1no record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Neurogene as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Neurogene
How much has Neurogene raised?
Neurogene has raised $194M across 2 rounds since 2019.
When did Neurogene last raise?
Neurogene's most recent round was an Undisclosed round of $125M in Jul 2026.
What was Neurogene's biggest round?
Its most recent round, $125M in Jul 2026, is also its largest on record.
Who backed Neurogene first?
Neurogene's first round on record, in Feb 2019, was backed by Cormorant Asset Management, Redmile Group and Samsara BioCapital and 1 others.
What stage is Neurogene at?
Neurogene's latest named round is an Undisclosed round, in Jul 2026.
Where is Neurogene based?
Neurogene is based in the United States.
Companies like Neurogene
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.